Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-26 · accession 0001654954-23-000929 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-27 | 2023-01-26 | AEHR | ROGERS VERNON | EVP Sales, Marketing | M - OptEx | $2.03 | +37.5K | 107.3K | +54% | +$76.1K |
| D | 2023-01-27 | 2023-01-26 | AEHR | ROGERS VERNON | EVP Sales, Marketing | M - OptEx | $0.00 | -37.5K | 110.3K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-26 | M | A | 37,500 | $2.03 | 107,275 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Derivative | Incentive Stock Option (right to buy) | 2023-01-26 | M | D | 37,500 | $0.00 | 110,283 | D | $2.03 · 2018-11-23 to 2025-10-23 | 37,500 Common Stock | (F2) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |